Pro Keall is granted for the title of “Cancer Imaging and Targeted Radiation Therapy: Innovation, Discovery and Translation“.
He is a Professor in the Sydney Medical School, an NHMRC Senior Principal Research Fellow and the Director of the ACRF Image X Institute at the University of Sydney. His team of scientists, clinical partners and international collaborators create, share and apply novel cancer imaging and targeted radiotherapy methods. Several of these innovations have been translated into clinical practice for improved health care.
Prof Keall’s research focuses on making radiotherapy treatment more effective and accessible. This is achieved by developing imaging and treatment technologies that maximise the radiation dose to the tumour while minimising it elsewhere. Many of these innovations can be implemented on existing treatment systems and are being used in clinical trials. Other innovations focus on broadening the applications of radiotherapy, from treating multiple lesions, to developing low-cost radiotherapy systems for developing countries and remote areas.
Sydney Vital would like to congratulate Prof Paul Keall and we are looking forward to seeing his research outcomes from the program.